5 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Orphan designations Remove Orphan designations filter
Medicine type
Accelerated assessment Remove Accelerated assessment filter
Generic Remove Generic filter
Conditional approval Remove Conditional approval filter
Opinion status
Positive Remove Positive filter
-
List item
Summary of opinion: Rybrevant
amivantamab, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Sapropterin Dipharma
sapropterin, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021 -
List item
Summary of opinion: Lorviqua
lorlatinib, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021 -
List item
Summary of opinion: Sitagliptin / Metformin hydrochloride Mylan
metformin hydrochloride, sitagliptin hydrochloride monohydrate, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021 -
List item
Summary of opinion: Kalydeco
ivacaftor, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021